Woodline Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-278,223
| Closed | -$12.1M | – | 700 |
|
2023
Q3 | $12.1M | Sell |
278,223
-95,109
| -25% | -$4.14M | 0.14% | 199 |
|
2023
Q2 | $13.5M | Buy |
373,332
+107,232
| +40% | +$3.87M | 0.16% | 171 |
|
2023
Q1 | $9.89M | Sell |
266,100
-370,617
| -58% | -$13.8M | 0.13% | 200 |
|
2022
Q4 | $28.8M | Buy |
636,717
+414,209
| +186% | +$18.8M | 0.39% | 60 |
|
2022
Q3 | $15.5M | Sell |
222,508
-71,059
| -24% | -$4.96M | 0.22% | 138 |
|
2022
Q2 | $19.7M | Buy |
293,567
+167,519
| +133% | +$11.2M | 0.3% | 97 |
|
2022
Q1 | $10.4M | Buy |
126,048
+1,156
| +0.9% | +$95K | 0.17% | 169 |
|
2021
Q4 | $18.3M | Buy |
124,892
+11,749
| +10% | +$1.72M | 0.26% | 114 |
|
2021
Q3 | $20M | Buy |
113,143
+18,867
| +20% | +$3.34M | 0.33% | 82 |
|
2021
Q2 | $15.2M | Buy |
94,276
+63,173
| +203% | +$10.2M | 0.28% | 95 |
|
2021
Q1 | $5.33M | Buy |
+31,103
| New | +$5.33M | 0.12% | 186 |
|
2020
Q3 | – | Sell |
-51,742
| Closed | -$5.91M | – | 222 |
|
2020
Q2 | $5.91M | Sell |
51,742
-49,211
| -49% | -$5.62M | 0.23% | 101 |
|
2020
Q1 | $7.76M | Buy |
+100,953
| New | +$7.76M | 0.55% | 59 |
|